The Correlation of L-citrulline Levels with Blood Pressure in Severe Preeclampsia

Hudila Rifa Karmia, Afriwardi Afriwardi, Hirowati Ali, Johanes Cornelius Mose, Yusrawati Yusrawati


BACKGROUND: Based on 'vascular disorder of pregnancy' terminology, preeclampsia primarily was not a hypertensive disorder, but a vascular disorder (general vasospasm) in pregnancy due to idiopathic etiology. The overall incidence of preeclampsia was 5-14% of all pregnancies. One of the substances responsible for regulating vascular tone is nitric oxide (NO), which produced in endothelial blood vessels. NO and L-citrulline are produced altogether by the reaction between L-arginine and oxygen. L-citrulline levels reflected NO production. This study was aimed to assess the correlation between the L-citrulline level and blood pressure in severe preeclampsia.

METHODS: This cross-sectional study was done in Dr. M. Djamil Central General Hospital, Padang, Indonesia The sample size was 36 samples of pregnant women with severe preeclampsia and had yet been given antihypertensive therapy. Sampling was done by consecutive sampling from Obstetrics and Gynecology Division. After maternal examination and measurements L-citrulline levels of cubital venous blood by using enzyme-linked immunosorbent assay (ELISA) method, Pearson correlation was performed to assess the relationship between variables for normally distributed data and Spearman's correlation for abnormal distribution data with significance level p<0.05.

RESULTS: Means of L-citrulline levels, systolic blood pressure, diastolic blood pressure, and arterial pressure (MAP) were 87.21 nmol/mL, 179.4 mmHg, 108.3
mmHg, and 132.1 mmHg, respectively. Correlation of the L-citrulline level with systolic blood pressure, diastolic blood pressure, and MAP were -0.08, -0.175, and -0.136 (p>0.05), respectively.

CONCLUSION: L-citrulline levels had no correlation with blood pressure in severe preeclampsia.

KEYWORDS: L-citrulline levels, blood pressure, severe preeclampsia

Full Text:



Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013; 170: 1-7, CrossRef.

Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013; 71: 18-25, CrossRef.

Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health services strengthening. J Pregnancy. 2011; 2011:481095, CrossRef.

Perpustakaan Fakultas Kedokteran Universitas Indonesia. Prevalensi preeklampsia berat di Rumah Sakit Ciptomangunkusumo. Jakarta: Perpustakaan Fakultas Kedokteran Universitas Indonesia; 2014.

Serudji J. Minimizing the occurrence and complications of preeclampsia: prevention and prediction. In: Pertemuan Ilmiah Tahunan (PIT) Fetomaternal XIII 2012 Mar 10-14, Palembang. Palembang: PIT Fetomaternal; 2012.

Matsubara K, Higaki T, Matsubara Y, Nawa A. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int J Mol Sci. 2015; 16: 4600-14, CrossRef.

Johal T, Lees CC, Everett TR, Wilkinson IB. The nitric oxide pathway and possible therapeutic options in pre-eclampsia. Br J Clin Pharmacol. 2014; 78: 244–57, CrossRef.

Hess S, Baker G, Gyenes G, Tsuyuki R, Newman S, Le Melledo J. Decreased serum L-arginine and L-citrulline levels in major depression. Psychppharmacology. 2017; 234: 3241-7, CrossRef.

Benedetto C, Marozio L, Neri I, Giarola M, Volpe A, Facchinetti F. Increased L-citrullinel-arginine plasma ratio in severe preeclampsia. Obstet Gynecol. 2000; 96: 395-9, CrossRef.

Zeng F, Zhu S, Wong MC, Yang Z, Tang J, Li K, et al. Associations between nitric oxide synthase 3 gene polymorphisms and preeclampsia risk: a meta-analysis. Sci Rep. 2016; 6: 23407, CrossRef.

Rai H, Parveen F, Kumar S, Kapoor A, Sinha N. Association of endothelial nitric oxide synthase gene polymorphisms with coronary artery disease: an updated meta-analysis and systematic review. PLoS One. 2014; 9: e113363, CrossRef.

Treuer AV and Gonzalez DR. Nitric oxide synthases, s-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities. Mol Med Rep. 2015; 11: 1555-65, CrossRef.

Berhan Y. No hypertensive disorder of pregnancy; no preeclampsiaeclampsia; no gestational hypertension; no. Hellp syndrome. Vascular disorder of pregnancy speaks for all. Ethiop J Health Sci. 2016; 26: 177-86, CrossRef.

Chen M, Tang W, Hou L, Liu R, Dong Z, Han X, et al. Tumor necrosis factor (TNF) -308G> A, nitric oxide synthase 3 (NOS3) + 894G> T polymorphisms and migraine risk: a meta-analysis. PlosOne. 2015; 10: e0129372, CrossRef.


Copyright (c) 2020 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute